HomeFENC • NASDAQ
add
Fennec Pharmaceuticals Inc
Previous close
$9.70
Day range
$9.46 - $9.85
Year range
$6.30 - $11.92
Market cap
259.35M USD
Avg Volume
150.96K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 9.74M | 534.20% |
Operating expense | 10.87M | 43.30% |
Net income | -2.68M | 60.89% |
Net profit margin | -27.55 | 93.83% |
Earnings per share | -0.14 | 48.03% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 13.27M | -44.19% |
Total assets | 26.86M | -0.28% |
Total liabilities | 38.49M | 30.43% |
Total equity | -11.62M | — |
Shares outstanding | 27.10M | — |
Price to book | -22.56 | — |
Return on assets | -19.81% | — |
Return on capital | -26.37% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -2.68M | 60.89% |
Cash from operations | -4.86M | 28.55% |
Cash from investing | — | — |
Cash from financing | 5.73M | 595.39% |
Net change in cash | 870.00K | 114.55% |
Free cash flow | -4.23M | 1.41% |
About
Founded
1996
Headquarters
Website
Employees
29